352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lincoln National's Compensation Committee adopted an amended Severance Plan for Officers on August 22, 2024, adding the chief executive officer as a participant. If the CEO is involuntarily terminated other than for cause, the CEO would receive two times annual base salary plus target annual bonus, paid over 104 weeks. The filing describes this as a compensation change with no financial results or operating events reported.
Plan amended and restated effective August 22, 2024, adding the CEO as a participating officer
Severance equals two times the CEO's annual base salary plus target annual incentive bonus, paid over 104 weeks
Other plan terms, as described in the April 11, 2024 proxy statement, remain unchanged; the full plan is filed as Exhibit 10.1
Arcosa closed a $600 million offering of 6.875% senior notes due 2032 on August 26, 2024, issued at 100% of face value. The company plans to use the proceeds, with expected borrowings under a Term Loan B facility due 2031, to fund its previously announced acquisition of the construction materials business of Stavola Holding Corporation. If the Stavola acquisition does not close by December 1, 2024, the notes must be redeemed at 100% of principal plus accrued interest, so the deal's completion affects this debt.
$600 million aggregate principal of 6.875% senior notes due August 15, 2032, sold at 100% of face value
Proceeds, with Term Loan B borrowings, to fund the Stavola Holding construction materials acquisition
Special redemption at 100% of principal plus accrued interest if the acquisition is not completed by December 1, 2024
Interest payable each February 15 and August 15, beginning February 15, 2025
LeMaitre Vascular said Chief Financial Officer Joseph P. Pellegrino Jr. will retire as an employee effective March 7, 2025, after the anticipated filing of the 2024 Form 10-K, and will remain on the Board of Directors. The company will search for a replacement CFO and expects Pellegrino to take part in the hiring process. The company also reaffirmed its August 1, 2024 financial guidance for Q3 and full-year 2024 as of August 26, 2024.
Pellegrino retires as an employee, including as CFO, effective March 7, 2025
He remains on the Board, serving out his term until June 2027 after being re-elected in June 2024
The company thanks him for 19 years of executive service and will search for a replacement CFO
Guidance from August 1, 2024 for Q3 2024 and Full-Year 2024 was reaffirmed as of August 26, 2024
Avista Corp. CEO Dennis Vermillion will step down as CEO and board member effective December 31, 2024, and retire by the end of the first quarter of 2025. The board appointed President and COO Heather Rosentrater as CEO and board member effective January 1, 2025, a planned succession the company described as long-term planning. Her compensation as CEO will be set at a later date.
Vermillion steps down as CEO and board member effective December 31, 2024; he will remain Executive Vice President and strategic advisor until retiring by the end of Q1 2025.
Heather Rosentrater, currently President and COO, becomes President and CEO and a board member effective January 1, 2025.
Rosentrater joined Avista in 1999 and became President and COO on October 1, 2023; she is the first female CEO in company history.
Compensation and employment terms for Rosentrater as CEO have not yet been determined.
United Bankshares increased its board to 15 members and appointed Dr. Sara DuMond as an independent director to fill the new seat, effective October 21, 2024. DuMond is a practicing pediatrician and founder and CEO of Pediatric Housecalls, PLLC, and the filing reports no financial results or deal terms.
Board size increased to 15 members on August 26, 2024, creating the seat DuMond fills
Appointment effective October 21, 2024; DuMond has not yet been named to any board committee
DuMond will receive compensation under the standard arrangements for non-employee directors described in the April 2, 2024 proxy statement
DuMond is founder and CEO of Pediatric Housecalls, PLLC, and a board-certified pediatrician
W.W. Grainger announced on August 26, 2024 that Matthew E. Fortin, its Senior Vice President and Chief Human Resources Officer, is no longer with the company, effective August 23, 2024. The filing does not give a reason for the departure or name a successor, and it describes no financial effect.
Matthew E. Fortin, Senior Vice President and Chief Human Resources Officer, is no longer with the company.
The departure is effective August 23, 2024; the company announced it on August 26, 2024.
The filing does not state a reason for the departure or name a replacement.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.